(19)
(11) EP 2 473 174 A2

(12)

(88) Date of publication A3:
07.07.2011

(43) Date of publication:
11.07.2012 Bulletin 2012/28

(21) Application number: 10814425.4

(22) Date of filing: 01.09.2010
(51) International Patent Classification (IPC): 
A61K 31/70(2006.01)
A61K 31/7028(2006.01)
A61K 9/08(2006.01)
A61P 25/00(2006.01)
A61K 31/7032(2006.01)
A61K 9/06(2006.01)
A61P 25/28(2006.01)
(86) International application number:
PCT/US2010/047527
(87) International publication number:
WO 2011/028799 (10.03.2011 Gazette 2011/10)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR

(30) Priority: 01.09.2009 US 238748 P

(71) Applicant: LZ Therapeutics, Inc.
Malvern, PA 19355 (US)

(72) Inventors:
  • SCHNEIDER, Jay, S.
    Cherry Hill NJ 08003 (US)
  • KOLENG, John, J.
    Austin TX 78750 (US)
  • FLORENTINE, Robert
    Macro Island FL 34145 (US)
  • ANDERSON, David, W.
    West Chester PA 19380 (US)

(74) Representative: Duffy, Assumpta Dympna et al
FRKelly 27 Clyde Road Ballsbridge
Dublin 4
Dublin 4 (IE)

   


(54) GANGLIOSIDE TRANSMUCOSAL FORMULATIONS